KIMBERLY KISER: Open Payments
NPI 1841716636 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,563 in 83 payments from 18 companies in 2025. Trend: 2023 $1,259 · 2024 $1,378 · 2025 $1,563
Food & beverage: $1,563
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $420 |
| Regeneron Healthcare Solutions, Inc. | 7 | $174 |
| Janssen Biotech, Inc. | 9 | $170 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $153 |
| Novo Nordisk Inc | 4 | $104 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $98 |
| Celltrion USA Inc. | 4 | $92 |
| Ardelyx, Inc. | 4 | $68 |
| Lilly USA, LLC | 3 | $46 |
| Aimmune Therapeutics, Inc. | 3 | $41 |
Products named: RINVOQ, DUPIXENT, TREMFYA, ENTYVIO, Wegovy, XIFAXAN, VEGZELMA, IBSRELA.
Industry payments across KY — which companies pay providers there.
